Northwest Biotherapeutics Opens Dedicated UK Clinic to Scale Immunotherapy Production
Northwest Biotherapeutics establishes dedicated UK leukapheresis clinic by June 2026, enabling scaled immunotherapy production and removing manufacturing bottlenecks.
NWBOpersonalized medicineglioblastoma